Exicure (XCUR) Accounts Payables (2016 - 2026)
Exicure (XCUR) reported Accounts Payables of $2.4 million for Q1 2026, up 102.07% on a YoY basis from $1.2 million in Q1 2025, and up 44.67% quarter-over-quarter from $1.7 million in Q4 2025.
Exicure (XCUR) Accounts Payables (2016 - 2026) Analysis & Trends
Exicure has reported Accounts Payables for 11 years, with the latest figure at $2.4 million in Q1 2026.
- For the quarter ending Q1 2026, Accounts Payables rose 102.07% year-over-year to $2.4 million; the trailing twelve-month figure through Mar 2026 stood at $2.4 million (up 102.07% YoY), and the FY2025 full-year result was $1.7 million, up 63.92% from the prior year.
- Accounts Payables for Q1 2026 stood at $2.4 million, up from $1.7 million in the prior quarter.
- The five-year high for Accounts Payables was $2.4 million in Q1 2026, with the low at $343000.0 in Q2 2023.
- Historically, Accounts Payables has averaged $1.3 million across 5 years, with a median of $1.3 million in 2024.
- Annual changes were most pronounced in 2022 — Accounts Payables tumbled 89.42% — and 2024, when it surged 362.1%.
- Exicure's Accounts Payables stood at $361000.0 in 2022, then soared by 351.8% to $1.6 million in 2023, then sank by 36.79% to $1.0 million in 2024, then jumped by 63.92% to $1.7 million in 2025, then soared by 44.67% to $2.4 million in 2026.
- The last three Accounts Payables figures came in at $2.4 million (Q1 2026), $1.7 million (Q4 2025), and $1.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 1.05 Mn |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 83.00 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 8.64 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 489.30 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 34.55 Mn |
| 10 | Exicure | 19.38 Mn | 16.77 Mn | - | 2.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.45 Mn |
| Dec 31, 2025 | 1.69 Mn |
| Sep 30, 2025 | 1.31 Mn |
| Jun 30, 2025 | 1.84 Mn |
| Mar 31, 2025 | 1.21 Mn |
| Dec 31, 2024 | 1.03 Mn |
| Sep 30, 2024 | 1.34 Mn |
| Jun 30, 2024 | 1.59 Mn |
| Mar 31, 2024 | 1.83 Mn |
| Dec 31, 2023 | 1.63 Mn |
| Sep 30, 2023 | 865,000.00 |
| Jun 30, 2023 | 343,000.00 |
| Mar 31, 2023 | 452,000.00 |
| Dec 31, 2022 | 361,000.00 |
| Sep 30, 2022 | 920,000.00 |
| Jun 30, 2022 | 1.59 Mn |
| Mar 31, 2022 | 1.92 Mn |
| Dec 31, 2021 | 3.41 Mn |
| Sep 30, 2021 | 2.49 Mn |
| Jun 30, 2021 | 2.25 Mn |